biospecimen banks

CPDR Patient Education Program

Special Clinic at WRNMMC for Men with Prostate Cancer

The Center for Prostate Disease Research (CPDR) at Walter ReedNational Military Medical Center (WRNMMC) has a special clinic for men diagnosed with prostate cancer called the "Multi-Disciplinary Prostate Cancer Clinic".

What is the purpose of the clinic?

To provide men (and their families) with information about their prostate cancer so they can make an informed decision on the best treatment for them.

Who is eligible to attend?

Military health care beneficiaries who are diagnosed with prostate cancer and have not yet made a treatment decision.

Why is it called "Multi-Disciplinary"?

Because men (and their families) will see staff members from a variety of disciplines --- surgery, radiation, sexual health, psychology, nursing, and research. The clinic is convenient and comprehensive by bringing everyone together on one day.

It is a comprehensive, multi-disciplinary, team-focused clinic. The goal of the clinic is to give men the medical team's recommendation on the best treatment (or treatments) for their prostate cancer based on their individual situation, and to provide information so they can make an informed decision on a treatment.

What happens in the clinic?

Each man (and their family) attending the clinic has 4 private consultations:

1) surgeon
2) radiation oncologist
3) urologist specializing in male sexual health and
4) psychologist.

There will also be 3 small group sessions:

1) welcome and orientation to the clinic
2) patient education and
3) research opportunities.

At the end of the clinic, a physician meets with each man privately to discuss the treatment (or treatments) that the medical team recommends.

How do I get into the clinic?

An appointment is required. (There is a maximum of 6 men for each clinic). Self-referrals are accepted. Call CPDR at 301-319-2900 for more information or to make an appointment.

When and where is the clinic conducted?

The clinic is held on Mondays at WRNMMC at the Center for Prostate Disease Research Clinic is conducted at WRNMMC
8901 Wisconsin Avenue, Bethesda, MD 20889.
America Building (Bldg #19), 3rd floor.
Parking is available in America Garage behind the America Building.

Hospital is located across from the National Institutes of Health, National Library of Medicine, and the Metro station ("Medical Center" red line).

CURRENT EVENTS


WRNMMC UsToo!
Quarterly Guest Speakers


Tschlitz

Dr. Philip Arlen
National Cancer Institute

Topic: "Prostate Cancer: An Overview and Update of Novel Treatment Modalities"
There have been remarkable advances in the therapy for prostate cancer over the past decade. We will be discussing these advances as well as new treatment options in clinical trials.

Date: Thursday 5 May 2016
Time: 1900-2030
Location: Walter Reed National Military Medical Center (America Building, 2nd floor, Room 2525) and Fort Belvoir Community Hospital (via video teleconference in Oaks Pavilion, 1st floor, Room 332).

Read the MAY 2016 WRNMMC UsToo! Newsletter

Go to WRNMMC UsToo! Newsletter Archive

 

February 2, 2016

CPDR Urology Residents Take Top Awards at 2016 James C. Kimbrough Urological Seminar

Urology Residents conducting research at The Center for Prostate Disease Research (CPDR), Department of Surgery, Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center presented their research at the Residents Competition category of the James C. Kimbrough Urological Seminar, San Diego, 2016.

Read Full Article

 

January 11, 2016

A Novel Gene Alteration Associates with Aggressive Prostate Cancer in African American Men

The USU, Walter Reed-Bethesda and JPC collaborative team, through comprehensive evaluations of matched cohorts of African American and Caucasian American prostate cancers, previously established a higher frequency of ERG alterations in Caucasians (50-70%) and its significantly lower frequency in African Americans (20-25%). These intriguing observations actually provided the rational for the current study focusing on whole genome evaluations of prostate cancers from these two patient populations.

Read Full Article